Tissue/Organ

2020 outlook for Longevity technology

Will 2020 be the year that sees a step change in Longevity? We review technology readiness levels for key Longevity domains. Yep, we have a...

Final frontier – 3D bioprinting in space

A strategic partnership between CELLINK and Made in Space promises advances for drug screening and cancer treatments. CELLINK, a Swedish bioprinter manufacturer, has announced a...

University of Minho to spin out bioprinting start-up

Research developments create a company focused on meniscus regeneration; seed funding planned for early 2020. One of the leading speakers at the recent 3D Bioprinting...

The Pentagon and Longevity tech opportunities

A released Pentagon report identifies research in areas with Longevity application - tech is moving fast and makes for intriguing reading. The US Military has...

Latest articles

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Cardiff University and Ervaxx turn to the dark side

Cardiff University is looking to Ervaxx and their Dark Antigens to build on research which could lead to a universal cancer treatment. Cardiff University’s world...

Young blood back on the menu

Exclusive interview: Ambrosia getting back to business after FDA warning. Research has demonstrated that giving old mice blood transfusions from younger mice shows signs of...

Precious nano metals hold key to new treatments

Metallic nanotechnology may turn out to be the most precious way to utilise metals, at least when it comes to increasing healthspan and lifespan. When...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.